Introduction. Different ferric and ferrous
iron preparations can be used as oral
iron supplements. Our aim was to compare the effects of oral ferric and ferrous
iron therapies in women with
iron deficiency anaemia. Methods. The present study included 104 women diagnosed with
iron deficiency anaemia after evaluation. In the evaluations performed to detect the aetiology underlying the
iron deficiency anaemia, it was found and treated. After the detection of the
iron deficiency anaemia aetiology and treatment of the underlying aetiology, the ferric group consisted of 30 patients treated with oral
ferric protein succinylate tablets (2 × 40 mg elemental
iron/day), and the second group consisted of 34 patients treated with oral ferrous
glycine sulphate
tablets (2 × 40 mg elemental
iron/day) for three months. In all patients, the following laboratory evaluations were performed before beginning treatment and
after treatment. Results. The mean haemoglobin and haematocrit increases were 0.95 g/dL and 2.62% in the ferric group, while they were 2.25 g/dL and 5.91% in the ferrous group, respectively. A significant difference was found between the groups regarding the increase in haemoglobin and haematocrit values (P < 0.05). Conclusion. Data are submitted on the good tolerability, higher efficacy, and lower cost of the ferrous preparation used in our study.